Marc Santos is a Guides Staff Writer from the Philippines. He's a seasoned writer with over four years of industry experience, and he is an enjoyer of all things difficult in gaming. If Marc's not ...

Pharma giant Eli Lilly tapped Walmart to offer in-store pickups of Zepbound vials, marking the first retail collaboration for its direct-to-consumer platform LillyDirect. Walmart, which operates ...

VIAL are trying to untether themselves from obsession on their new track, “IDLE HANDS,” out now via Trout Hole Records. Written and recorded in the midst of heartbreak, “IDLE HANDS” is a fiery, ...

The chips that datacenters use to run the latest AI breakthroughs generate much more heat than previous generations of silicon. Anybody whose phone or laptop has overheated knows that electronics ...

Historically, making a thin phone meant trading the usual battery for one that's slimmer and less robust. And what good is a thin phone with poor battery life? Up-and-coming silicon-carbon battery ...

Carbon dioxide consumes our thoughts – and rightly so. Its emission from power plants, car exhausts and the burning of natural habitats is making our world warmer and warmer – a fact seriously ...

Shrinking silicon transistors have reached their physical limits, but a team from the University of Tokyo is rewriting the rules. They've created a cutting-edge transistor using gallium-doped indium ...

Scientists have developed a fuel cell system which they say could ultimately have enough energy capacity to power regional electric aircraft. They state that the technology is capable of carrying over ...

Ms. Hao is the author of “Empire of AI: Dreams and Nightmares in Sam Altman’s OpenAI.” On his second day in office this year, President Trump underscored his unequivocal support for the tech industry.

New pricing aims to attract cash-paying customers via LillyDirect Hims & Hers warns it may stop selling compounded version of Novo Nordisk weight-loss drugs Telehealth firms' shares fall The move ...

Eli Lilly is unleashing new ammunition in its fight against cheaper, compounded versions of its obesity blockbuster Zepbound. The Indiana-based drugmaker is slashing the prices of its 2.5 mg ...